311 related articles for article (PubMed ID: 12616432)
1. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma.
Gerhards MF; van Gulik TM; González González D; Rauws EA; Gouma DJ
World J Surg; 2003 Feb; 27(2):173-9. PubMed ID: 12616432
[TBL] [Abstract][Full Text] [Related]
2. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
[TBL] [Abstract][Full Text] [Related]
3. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
Kaiser GM; Frühauf NR; Lang H; Sauerwein W; Sotiropoulos GC; Zöpf T; Grabellus F; Wittig A; Oldhafer KJ; Malagó M; Broelsch CE
Hepatogastroenterology; 2008; 55(88):1951-4. PubMed ID: 19260456
[TBL] [Abstract][Full Text] [Related]
4. Surgical procedure and prognosis of hilar cholangiocarcinoma.
Yi B; Zhang BH; Zhang YJ; Jiang XQ; Zhang BH; Yu WL; Chen QB; Wu MC
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):453-7. PubMed ID: 15313688
[TBL] [Abstract][Full Text] [Related]
5. Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stenting.
Ishii H; Furuse J; Nagase M; Kawashima M; Ikeda H; Yoshino M
Hepatogastroenterology; 2004; 51(58):954-7. PubMed ID: 15239222
[TBL] [Abstract][Full Text] [Related]
6. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.
Ben-David MA; Griffith KA; Abu-Isa E; Lawrence TS; Knol J; Zalupski M; Ben-Josef E
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):772-9. PubMed ID: 17011452
[TBL] [Abstract][Full Text] [Related]
7. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J
Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
[TBL] [Abstract][Full Text] [Related]
8. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
[TBL] [Abstract][Full Text] [Related]
9. Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma.
Wu Y; Johlin FC; Rayhill SC; Jensen CS; Xie J; Cohen MB; Mitros FA
Liver Transpl; 2008 Mar; 14(3):279-86. PubMed ID: 18306329
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD
Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027
[TBL] [Abstract][Full Text] [Related]
11. External radiotherapy for biliary decompression of hilar cholangiocarcinoma.
Ohnishi H; Asada M; Shichijo Y; Iijima N; Itobayashi E; Shimura K; Suzuki T; Yoshida S; Mine T
Hepatogastroenterology; 1995 Jul; 42(3):265-8. PubMed ID: 7590576
[TBL] [Abstract][Full Text] [Related]
12. Our experiences in surgical treatment for hilar cholangiocarcinoma.
Maeno H; Ono T; Yamanoi A; Nagasue N
Hepatogastroenterology; 2007; 54(75):669-73. PubMed ID: 17591038
[TBL] [Abstract][Full Text] [Related]
13. Intraluminal high dose rate brachytherapy in the treatment of bile duct and gallbladder carcinomas.
Dvorák J; Jandík P; Melichar B; Jon B; Mergancová J; Zoul Z; Vacek Z; Petera J
Hepatogastroenterology; 2002; 49(46):916-7. PubMed ID: 12143240
[TBL] [Abstract][Full Text] [Related]
14. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
[TBL] [Abstract][Full Text] [Related]
15. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A
In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762
[TBL] [Abstract][Full Text] [Related]
16. Surgical therapy for hiliar cholangiocarcinoma: analysis of 198 cases.
Zhang BH; Cheng QB; Luo XJ; Zhang YJ; Jiang XQ; Zhang BH; Yi B; Yu WL; Wu MC
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):278-82. PubMed ID: 16698591
[TBL] [Abstract][Full Text] [Related]
17. Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors.
Schleicher UM; Staatz G; Alzen G; Andreopoulos D
Strahlenther Onkol; 2002 Dec; 178(12):682-7. PubMed ID: 12491056
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation for hilar cholangiocarcinoma.
Thelen A; Neuhaus P
J Hepatobiliary Pancreat Surg; 2007; 14(5):469-75. PubMed ID: 17909715
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
[TBL] [Abstract][Full Text] [Related]
20. Brachytherapy in the treatment of cholangiocarcinoma.
Shinohara ET; Guo M; Mitra N; Metz JM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):722-8. PubMed ID: 20207503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
